### 38112 Federal Register / Vol. 75, No. 126 / Thursday, July 1, 2010 / Notices

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Agency for Healthcare Research and Quality** 

**Notice of Meeting**

In accordance with section 10(d) of the Federal Advisory Committee Act (5 U.S.C., Appendix 2), announcement is made of a Health Care Policy and Research Special Emphasis Panel (SEP) meeting.

A Special Emphasis Panel is a group of experts in fields related to health care research who are invited by the Agency for Healthcare Research and Quality (AHRQ), and agree to be available, to conduct on an as needed basis, scientific reviews of applications for AHRQ support. Individual members ofthe Panel do not attend regularlyscheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in particular review meetings which require their type of expertise.

Substantial segments of the upcoming SEP meeting listed below will be closed to the public in accordance with the Federal Advisory Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 552b(c)(6). Grant applications for the Accelerating Implementation of Evidence-Based Findings through AHRQ networks (R18) applications are to be reviewed and discussed at this meeting. These discussions are likely to reveal personal information concerning individuals associated with the applications. This information is exempt from mandatory disclosure under the above-cited
statutes.

SEP Meeting on: Accelerating Implementation of Evidence-Based Findings through AHRQ networks (R18).

Date: July 23, 2010 (Open on July 23 from 12 p.m. to 12:15 p.m. and closed for the remainder of the meeting).

Place: Doubletree Bethesda Hotel & Executive Meeting Center, 8120 Wisconsin Avenue, Conference Room TBD, Bethesda, Maryland 20852.

Contact Person: Anyone wishing to obtain a roster of members, agenda or minutes of the non—confidential portions of this meeting should contact Mrs. Bonnie Campbell, Committee Management Officer, Office of Extramural Research, Education and Priority Populations, AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, Telephone (301) 427–1554.

Agenda items for this meeting are subject to change as priorities dictate.

Dated: June 23, 2010. Carolyn M. Clancy,

Director.
[FR Doc. 2010–15792 Filed 6–30–10; 8:45 am]

**BILLING CODE 4160–90–M DEPARTMENT OF HEALTH AND**  **HUMAN SERVICES**

**Substance Abuse and Mental Health Services Administration** 

**Center for Substance Abuse Treatment; Notice of Meeting** 

Pursuant to Public Law 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Treatment (CSAT) National Advisory Council will meet July 14, 2010, 1–3 p.m. via teleconference.

The meeting will include discussion and evaluation of grant applications reviewed by Initial Review Groups. Therefore, the meeting will be closed to the public as determined by the Administrator, SAMHSA, in accordance with Title 5 U.S.C. 552b(c)(6) and 5 U.S.C. App. 2, Section 10(d).

Substantive program information, a summary of the meeting and a roster of Council members may be obtained as soon as possible after the meeting, either by accessing the SAMHSA Committee Web site at https://nac.samhsa.gov/ CSATcouncil/index.aspx, or by contacting the CSAT National Advisory Council Designated Federal Official, Ms. Cynthia Graham ( see contact information below).

Committee Name: SAMHSA’s Center for Substance Abuse Treatment National Advisory Council

Date/Time/Type: July 14, 2010, 1–3 p.m.: Closed.

Place: SAMHSA Building, 1 Choke Cherry Road, Rock Creek Room, Rockville, Maryland

20857.

Contact: Cynthia Graham, M.S., Designated Federal Official, SAMHSA CSAT National Advisory Council, 1 Choke Cherry Road, Room 5–1035, Rockville, Maryland 20857, Telephone: (240) 276–1692, Fax: (240) 276–
1690, E-mail: cynthia.graham@samhsa.hhs.gov.

Toian Vaughn, Committee Management Officer, Substance Abuse and Mental Health, Services Administration.
[FR Doc. 2010–15940 Filed 6–30–10; 8:45 am]

**BILLING CODE 4162–20–P DEPARTMENT OF HEALTH AND**  **HUMAN SERVICES**

**Indian Health Service**

**Organization, Functions, and Delegations of Authority; Part G;**  **Indian Health Service; Proposed Functional Statement** 
Program Integrity and Ethics Staff (PIES) (GAL1)

(1) Directs the fact-finding and resolution of allegations of impropriety such as mismanagement of resources, fraud, waste, and abuse, violations of the Standards of Ethical Conduct, Hatch Act and political activity and other forms of waste; (2) advises the IHS Director and IHS management of appropriate corrective and remedial actions to correct improprieties; (3) directs and provides leadership in the formulation of plans, guidance, and evaluation of the IHS Personnel Security and Drug Testing Programs; (4) administers the IHS-wide management of the Agency hotline reports of allegations; (5) manages and directs the IHS ‘‘Ethics Program, ’’ including the implementation of all requirements, providing advice to the IHS Director and serving as the Agency liaison with all outside investigative organizations such as the Office of Special Counsel, the Government Accountability Office (GAO) and HHS Office of Inspector General (OIG); (6) develops and implements IHS directives and training for Standards of Ethical Conduct, the Hatch Act and political activity, allegations and investigations of administrative fraud, waste and abuse, drug testing, and personnel security; and (7) serves as the IHS liaison with the OIG and GAO, and coordinates the development, clearance, and transmittal of IHS responses and follow-up to matters and reports issued by the OIG, the GAO, and other Federal internal and external authorities. Management Policy and Internal Control Staff (MPICS) (GAL3)

(1) Formulates, administers, and supports IHS-wide policies, delegations of authority, and organizations and functions development; (2) provides leadership, on behalf of the IHS Director, to functional area managers at IHS Headquarters in developing, modifying, and overseeing the implementation of IHS policies and procedures; (3) provides analysis, advisory, and assistance services to IHS managers and staff for the development, clearance, and filing of IHS directives and delegations of authority; (4) serves as principal advisor and source for